skip navigation

Justinfo Subscribe to Stay Informed

Add your conference to our Justice Events calendar


NCJRS Abstract


Subscribe to Stay Informed
Want to be in the know? JUSTINFO is a biweekly e-newsletter containing information about new publications, events, training, funding opportunities, and Web-based resources available from the NCJRS Federal sponsors. Sign up to get JUSTINFO in your inbox.

The document referenced below is part of the NCJRS Library collection.
To conduct further searches of the collection, visit the NCJRS Abstracts Database.

How to Obtain Documents
NCJ Number: NCJ 241874     Find in a Library
Title: Briefing on PMP Effectiveness -- Prescription Monitoring Programs: An Effective Tool in Curbing the Prescription Drug Abuse Epidemic
  Document URL: PDF 
Corporate Author: Prescription Montoring Programs Ctr of Excellence
United States of America
Date Published: 03/2012
Page Count: 8
  Annotation: This report concludes that there is growing evidence that prescription monitoring programs (PMPs) are effective in reducing diversion of controlled substances, improving clinical decisionmaking, and assisting in other efforts to curb the prescription drug abuse epidemic.
Abstract: The importance of PMPs is clear from evidence that addiction, overdoses, and deaths that involve non-medical prescription drug use have increased significantly over the last decade, surpassing those due to illicit drugs such as heroin and cocaine. Narcotic pain relievers are the most abused of the non-medical prescription drugs. PMPs collect data from pharmacies on dispensed controlled substance prescriptions. PMPs are important tools in curbing major sources of prescription drug diversion, which include prescription fraud, forgeries, doctor shopping, and medically unwarranted prescribing by some practitioners and pharmacists. Currently, 48 States and 1 U.S. Territory have enacted legislation that establishes a PMP; 38 States have operational PMPs. This report presents a sampling of studies that show PMPs can help in improving prescribing procedures and reducing the diversion of controlled substances. The studies indicate that States with PMPs and States with pro-active PMPs have lower rates of treatment admissions for the abuse of prescription drugs, reduced doctor shopping, and less diversion of non-medical prescription drugs. Also, States with PMPs have smaller increases in opiate exposures related to abuse and misuse, as well as lower outpatient drug claims. In addition, States without PMPs are more likely to experience higher rates of controlled substance distribution. Studies also indicate that PMP data have assisted in the investigation of drug diversion and reduced the number of investigations needed. Other benefits of PMPs include assisting in drug abuse prevention and surveillance, as well as the validation of patient self-reports on the use of medications. 35 notes
Main Term(s): Drug prevention programs
Index Term(s): Opiates ; Drug law enforcement ; Effectiveness ; Investigative techniques ; Prescription drugs ; BJA grant-related documents
Sponsoring Agency: Bureau of Justice Assistance
US Dept of Justice
Office of Justice Programs
United States of America
Grant Number: 2009-PM-BX-K044
Type: Program/Project Description ; Program/Project Evaluation ; Report (Grant Sponsored)
Country: United States of America
Language: English
  To cite this abstract, use the following link:

* A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's web site is provided.